BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Aljumah AA, Saeed MA, Al Flaiw AI, Al Traif IH, Al Alwan AM, Al Qurashi SH, Al Ghamdi GA, Al Hejaili FF, Al Balwi MA, Al Sayyari AA. Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. World J Gastroenterol 2012; 18(1): 55-63 [PMID: 22228971 DOI: 10.3748/wjg.v18.i1.55]
URL: https://www.wjgnet.com/1007-9327/full/v18/i1/55.htm
Number Citing Articles
1
Qussai Hassan, Bruno Roche, Camille Buffet, Thomas Bessede, Didier Samuel, Bernard Charpentier, Antoine Durrbach. Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alphaTransplant International 2012; 25(9): 941 doi: 10.1111/j.1432-2277.2012.01520.x
2
AbdullahS Alghamdi, FaisalM Sanai, Mona Ismail, Hamdan Alghamdi, Khalid Alswat, Adel Alqutub, Ibrahim Altraif, Hemant Shah, FalehZ Alfaleh. SASLT practice guidelines: Management of hepatitis C virus infectionSaudi Journal of Gastroenterology 2012; 18(7): 1 doi: 10.4103/1319-3767.101155
3
Faisal M. Sanai, Dujana Mousa, Abdallah Al-Mdani, Ghada Al-Shoail, Hamad Al-Ashgar, Khalid Al Meshari, Ahmed Al-Qahtani, Mayssa Saadeh, Khalid I. Bzeizi, Hassan Aleid. Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis CJournal of Hepatology 2013; 58(6): 1096 doi: 10.1016/j.jhep.2013.02.004
4
Sara Belga, Karen Elizabeth Doucette. Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizonWorld Journal of Gastroenterology 2016; 22(4): 1650-1663 doi: 10.3748/wjg.v22.i4.1650
5
Current World LiteratureCurrent Opinion in Organ Transplantation 2012; 17(6): 688 doi: 10.1097/MOT.0b013e32835af316
6
Fang Wei, Junying Liu, Fen Liu, Huaidong Hu, Hong Ren, Peng Hu, Wenzhe Ho. Interferon-Based Anti-Viral Therapy for Hepatitis C Virus Infection after Renal Transplantation: An Updated Meta-AnalysisPLoS ONE 2014; 9(4): e90611 doi: 10.1371/journal.pone.0090611
7
Marco Carbone, David Mutimer, James Neuberger. Hepatitis C Virus and Nonliver Solid Organ TransplantationTransplantation 2013; 95(6): 779 doi: 10.1097/TP.0b013e318273fec4
8
Roberto J Carvalho-Filho, Ana Cristina CA Feldner, Antonio Eduardo B Silva, Maria Lucia G Ferraz. Management of hepatitis C in patients with chronic kidney diseaseWorld Journal of Gastroenterology 2015; 21(2): 408-422 doi: 10.3748/wjg.v21.i2.408
9
Cyrielle Delabaudière, Laurence Lavayssière, Gaëlle Dörr, Fabrice Muscari, Marie Danjoux, Federico Sallusto, Jean Marie Peron, Christophe Bureau, Lionel Rostaing, Jacques Izopet, Nassim Kamar. Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney-liver transplantationTransplant International 2015; 28(2): 255 doi: 10.1111/tri.12428
10
Chalermrat Bunchorntavakul, Monthira Maneerattanaporn, Disaya Chavalitdhamrong. Management of patients with hepatitis C infection and renal diseaseWorld Journal of Hepatology 2015; 7(2): 213-225 doi: 10.4254/wjh.v7.i2.213
11
Siu-ka Mak, Ho-kwan Sin, Kin-yee Lo, Man-wai Lo, Shuk-fan Chan, Kwok-chi Lo, Yuk-yi Wong, Lo-yi Ho, Ping-nam Wong, Andrew K. M. Wong. Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-upClinical and Experimental Nephrology 2017; 21(5): 764 doi: 10.1007/s10157-016-1364-7
12
D. B. Korman, L. A. Ostrovskaya, V. A. Kuz’min. Induction of Oxidative Stress in Tumor Cells: A New Strategy for Drug Therapy of Malignant TumorsBiophysics 2019; 64(3): 431 doi: 10.1134/S0006350919030102
13
Aamir Bashir, Ashish Verma, Ajay Duseja, Arka De, Pramil Tiwari. Adjuvant Use of Ribavirin With Treatment of Hepatitis C Virus in Kidney Transplant RecipientsIndian Journal of Transplantation 2022; 16(3): 243 doi: 10.4103/ijot.ijot_10_22
14
Yuvaram N. V. Reddy, David Nunes, Vipul Chitalia, Craig E. Gordon, Jean M. Francis. Hepatitis C virus infection in kidney transplantation‐changing paradigms with novel agentsHemodialysis International 2018; 22(S1) doi: 10.1111/hdi.12659
15
Anais Vallet-Pichard, Stanislas Pol. Hepatitis C virus infection in hemodialysis patientsClinics and Research in Hepatology and Gastroenterology 2013; 37(4): 340 doi: 10.1016/j.clinre.2013.03.005
16
S. Baid-Agrawal, M. Pascual, D. Moradpour, R. Somasundaram, M. Muche. Hepatitis C Virus Infection and Kidney Transplantation in 2014: What’s New?American Journal of Transplantation 2014; 14(10): 2206 doi: 10.1111/ajt.12835
17
Susan M. Lerner. Hepatitis C and Renal TransplantationMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 2012; 79(3): 342 doi: 10.1002/msj.21318
18
Jose M. Morales, Fabrizio Fabrizi. Hepatitis C and its impact on renal transplantationNature Reviews Nephrology 2015; 11(3): 172 doi: 10.1038/nrneph.2015.5
19
Jonathan Grinstein, Laura M. Lourenco, Helen S. Te, John F. Renz, Valluvan Jeevanandam, Nir Uriel. Accepting Hearts From Hepatitis C–Positive Donor: Can We Expand the Donor Pool?Journal of Cardiac Failure 2017; 23(10): 762 doi: 10.1016/j.cardfail.2017.05.018
20
Calvin K. W. Tong, Kiran K. Khush. New Approaches to Donor Selection and Preparation in Heart TransplantationCurrent Treatment Options in Cardiovascular Medicine 2021; 23(5) doi: 10.1007/s11936-021-00906-5
21
Fabrizio Fabrizi, Alessandra Penatti, Piergiorgio Messa, Paul Martin. Treatment of hepatitis C after kidney transplant: A pooled analysis of observational studiesJournal of Medical Virology 2014; 86(6): 933 doi: 10.1002/jmv.23919